Y-Intercept (HK)’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Buy
610,094
+453,081
+289% +$3M 0.07% 406
2026
Q1
$1.14M Buy
+157,013
New +$2.05M 0.02% 978
2025
Q2
Sell
-35,691
Closed -$288K 2069
2025
Q1
$288K Buy
35,691
+13,007
+57% +$142K 0.02% 919
2024
Q4
$281K Sell
22,684
-6,875
-23% -$91.8K 0.02% 952
2024
Q3
$242K Sell
29,559
-39,244
-57% -$235K 0.01% 1089
2024
Q2
$343K Buy
+68,803
New +$393K 0.02% 979
2023
Q2
Sell
-21,667
Closed -$93.8K 1777
2023
Q1
$93.8K Buy
+21,667
New +$99.3K 0.01% 1060
2022
Q3
Sell
-11,295
Closed -$37K 1315
2022
Q2
$37K Buy
+11,295
New +$21.7K ﹤0.01% 770

Other funds holding WVE

Y-Intercept (HK)'s WVE Position: Q2 2026 in Review

Y-Intercept (HK) increased its Wave Life Sciences (WVE) stake by 289% in Q2 2026, buying an estimated $3M and bringing the position to 610,094 shares worth $3.54M. The position accounts for 0.07% of the portfolio, ranked #406.

Y-Intercept (HK) first reported a position in WVE in Q2 2022 and has held it in 8 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Y-Intercept (HK) held 610,094 shares of Wave Life Sciences worth $3.54M as of Q2 2026.
  • Y-Intercept (HK) bought 453,081 Wave Life Sciences shares in Q2 2026, an estimated $3M.
  • Wave Life Sciences made up 0.07% of Y-Intercept (HK)'s portfolio in Q2 2026, its #406 holding.
  • Y-Intercept (HK) first reported a position in Wave Life Sciences in Q2 2022 and has held it in 8 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.